These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 19666764)

  • 1. A 50-year-old woman with dyspnea, lower extremity edema, and volume loss of the right hemithorax.
    Shostak E; Sarwar A
    Chest; 2009 Aug; 136(2):628-632. PubMed ID: 19666764
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of nesiritide vs. epoprostenol in a patient with precapillary pulmonary hypertension due to scleroderma complicated by postcapillary pulmonary hypertension.
    Zakir RM; Berkowitz RL; Saric M; Ashtyani H
    Congest Heart Fail; 2005; 11(6):331-4. PubMed ID: 16330910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case series of patients with severe pulmonary hypertension receiving an implantable pump for intravenous prostanoid therapy.
    Ewert R; Halank M; Bruch L; Ghofrani HA
    Am J Respir Crit Care Med; 2012 Dec; 186(11):1196-8. PubMed ID: 23204382
    [No Abstract]   [Full Text] [Related]  

  • 4. Continuous epoprostenol therapy and septal defect closure in a patient with severe pulmonary hypertension.
    Hirabayashi A; Miyaji K; Akagi T
    Catheter Cardiovasc Interv; 2009 Apr; 73(5):688-91. PubMed ID: 19133673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversible pulmonary hypertension in a patient treated with protacyclin.
    Engel PJ; Baughman R; Johnson H; Kereikes DJ
    J Invasive Cardiol; 2004 Nov; 16(11):660-2. PubMed ID: 15550741
    [No Abstract]   [Full Text] [Related]  

  • 6. Effectiveness of transition from intravenous epoprostenol to oral/inhaled targeted pulmonary arterial hypertension therapy in pediatric idiopathic and familial pulmonary arterial hypertension.
    Melnick L; Barst RJ; Rowan CA; Kerstein D; Rosenzweig EB
    Am J Cardiol; 2010 May; 105(10):1485-9. PubMed ID: 20451700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term continuous intravenous infusion of prostacyclin for severe primary pulmonary hypertension.
    Okano Y; Senju S; Tsutsui Y; Kyotani S; Ishibashi M; Yoshida M; Kunieda T
    Intern Med; 1997 Nov; 36(11):794-8. PubMed ID: 9392352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of epoprostenol on right ventricular hypertrophy and dilatation in pulmonary hypertension.
    Roeleveld RJ; Vonk-Noordegraaf A; Marcus JT; Bronzwaer JG; Marques KM; Postmus PE; Boonstra A
    Chest; 2004 Feb; 125(2):572-9. PubMed ID: 14769740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary edema complicating continuous intravenous prostacyclin in pulmonary capillary hemangiomatosis.
    Humbert M; Maître S; Capron F; Rain B; Musset D; Simonneau G
    Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1681-5. PubMed ID: 9603154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of pulmonary hypertension and subsequent repair of atrial septal defect after treatment with continuous intravenous epoprostenol.
    Frost AE; Quiñones MA; Zoghbi WA; Noon GP
    J Heart Lung Transplant; 2005 Apr; 24(4):501-3. PubMed ID: 15797757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EPITOME-2: An open-label study assessing the transition to a new formulation of intravenous epoprostenol in patients with pulmonary arterial hypertension.
    Sitbon O; Delcroix M; Bergot E; Boonstra AB; Granton J; Langleben D; Subías PE; Galiè N; Pfister T; Lemarié JC; Simonneau G
    Am Heart J; 2014 Feb; 167(2):210-7. PubMed ID: 24439982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transition from IV to subcutaneous prostacyclin: premature withdrawal?
    Shapiro S; Hill NS
    Chest; 2007 Sep; 132(3):741-3. PubMed ID: 17873184
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma brain natriuretic peptide as a parameter to assess efficacy of continuous intravenous infusion of prostacyclin (epoprostenol) to treat severe primary pulmonary hypertension: a case report.
    Wakaumi M; Shiga T; Nozaki K; Fujiu K; Shimaya K; Ishizuka N; Matsuda N; Kasanuki H
    Heart Vessels; 2000; 15(3):144-6. PubMed ID: 11289503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous and inhaled epoprostenol for primary pulmonary hypertension during pregnancy and delivery.
    Bildirici I; Shumway JB
    Obstet Gynecol; 2004 May; 103(5 Pt 2):1102-5. PubMed ID: 15121623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous intravenous administration of a low dose of epoprostenol greatly decreased serum concentrations of endothelin-1 in primary pulmonary hypertension--a case report.
    Kakinuma Y; Honma S; Morimoto T; Maruyama H; Yamazaki A; Ishimitsu T; Yamaguchi I
    Angiology; 2005; 56(5):641-5. PubMed ID: 16193207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose epoprostenol improved pulmonary hypertension in a patient with systemic lupus erythematosus.
    Matsukawa Y; Igei K; Nozaki T; Ohki T; Shimizu T; Kitamura N; Mitamura K; Takei M; Kasamaki Y; Sawada S
    Clin Rheumatol; 2007 Apr; 26(4):582-3. PubMed ID: 16391888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up after conversion from intravenous epoprostenol to oral therapy with bosentan or sildenafil in 13 patients with pulmonary arterial hypertension.
    Johnson RF; Loyd JE; Mullican AL; Fink CA; Robbins IM
    J Heart Lung Transplant; 2007 Apr; 26(4):363-9. PubMed ID: 17403478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital right pulmonary artery agenesis with atrial septal defect and pulmonary hypertension.
    Orun UA; Yilmaz O; Bilici M; Karademir S; Uner C; Senocak F; Dogan V
    Congenit Heart Dis; 2012; 7(3):E6-9. PubMed ID: 21801314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low incidence of catheter-related complications in patients with advanced pulmonary arterial hypertension undergoing continuous epoprostenol infusion.
    Nagai T; Kohsaka S; Anzai T; Yoshikawa T; Fukuda K; Sato T
    Chest; 2012 Jan; 141(1):272-273. PubMed ID: 22215838
    [No Abstract]   [Full Text] [Related]  

  • 20. Is magnetic resonance imaging of right ventricular volume useful clinically for evaluation of pulmonary arterial hypertension?
    Hirashiki A; Kondo T; Murohara T
    Circ J; 2012; 76(7):1595-6. PubMed ID: 22665072
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.